LD-2 disclosure · 2nd Quarter - Report
PRIME THERAPEUTICS
Client
- Location
- Minnesota · United States of America
Registrant
- Description
- Pharmacy Benefit Management
- Location
- Eagan, Minnesota, United States of America
Lobbying activities
3 issuesHealth Issues
H.R.2214: The DRUG Act, provisions related to PBM compensation. S.891: The Bipartisan Health Care Act, provisions related to PBM regulation. H.R.10445 (118th Congress): Further Consolidating Appropriations and Disaster Relief Supplemental Appropriations Act, Division E, Healthcare, provisions regulating pharmacy benefit managers. H.R.5378 (118th Congress): Lower Cost, More Transparency Act. S.526 Pharmacy Benefit Manger Transparency Act of 2025, provisions related to transparency and pharmacy and PBM compensation. S.1339 PBM Reform Act (118th Congress): provisions related to PBM compensation.
LobbyistsJULIE CAROL CANTOR-WEINBERG
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
S.832: EPIC Act, provisions on eligibility for Medicare drug price negotiation. S.891: The Bipartisan Health Care Act, provisions related to PBM regulation. H.R.10445 (118th Congress): Further Consolidating Appropriations and Disaster Relief Supplemental Appropriations Act, Division E, Healthcare, provisions regulating pharmacy benefit managers. H.R.5378 (118th Congress): Lower Cost, More Transparency Act. H.R.1: The One Big Beautiful Bill (House version), provisions on PBM transparency, audit rights and payments.
LobbyistsJULIE CAROL CANTOR-WEINBERG
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS)
Trade (domestic/foreign)